Impact of nucleos(t)ide analog treatment on the development of malignancy in patients with chronic hepatitis B

We evaluated whether nucleos(t)ide analog (NA) influences the risk of non-hepatocellular carcinoma (non-HCC) malignancies in patients with chronic hepatitis B (CHB). A total of 9867 patients with CHB were followed up for ≥12 months for the occurrence of any type of malignancy between 1998 and 2013....

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Medicine (Baltimore)
Autori principali: Kim, Soon Sun, Ahn, Eun Kyoung, Cho, Soo Yeon, Park, Rae Woong, Cho, Hyo Jung, Kim, Ji-Hyun, Kim, Han Gyeol, Lee, Ga Ram, Hwang, Sun Hyuk, Yang, Min Jae, Cheong, Jae Youn, Cho, Sung Won
Natura: Artigo
Lingua:Inglês
Pubblicazione: Wolters Kluwer Health 2018
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6023687/
https://ncbi.nlm.nih.gov/pubmed/29901622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000011087
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi